Cook, Los Angeles, Miami-Dade counties most at risk of measles outbreak, study finds

Morguefile.com
- Morguefile.com
0Comments

Illinois’ Cook County is the U.S. jurisdiction most at risk of a measles outbreak this year, according to a study published this month in the British medical journal The Lancet Infectious Diseases.

The study titled “Measles resurgence in the USA: How international travel compounds vaccine resistance” includes a predictive model showing the 25 counties that face the largest risk of new measles cases.

Other counties on the list most at risk of a measles breakout include Los Angeles, Miami-Dade and Queens. The degree of risk was measured on a scale of zero to 1.000, the highest probability.

The analysis measured four key factors to determine the likeliest locations for measles outbreaks: international air travel volume to the county, the existence of nonmedical exemptions that would lower vaccination rates, the county’s population and rates of measles outbreaks in the countries international visitors are coming from.

So far this year, close to 900 measles cases have been reported in 24 states, according to the federal Centers for Disease Control and Prevention (CDC). That’s more cases than any year since 2000 when the highly contagious disease was declared eradicated, the CDC reported.

Counties With Highest Risk for Measles in 2019

Rank County State  Relative Risk
1 Cook Illinois 1.000
2 Los Angeles California 0.432
3 Miami-Dade Florida 0.381
4 Queens New York 0.293
5 King Washington 0.140
6 Maricopa Arizona 0.123
7 Broward Florida 0.106
8 Clark Nevada 0.093
9 Harris Texas 0.087
10 Honolulu Hawaii 0.067
11 Wayne Michigan 0.052
12 Tarrant Texas 0.048
13 Multnomah Oregon 0.047
14 Orange Florida 0.046
15 Essex New Jersey 0.045
16 Denver Colorado 0.022
17 Hillsborough Florida 0.019
18 San Mateo California 0.019
19 Salt Lake City Utah 0.018
20 Suffolk Massachusetts 0.017
21 Clayton Georgia 0.013
22 Travis Texas 0.013
23 Hennepin Minnesota 0.012
24 Loudoun Virginia 0.012
25 San Diego California 0.010

Source: The Lancet Infectious Diseases



Leave a Reply

Your email address will not be published. Required fields are marked *

Related

LOCATE BIO: CognitOss Granted FDA Breakthrough Device Designation

LOCATE BIO: CognitOss Granted FDA Breakthrough Device Designation

CognitOss is designed to treat osteomyelitis, a debilitating inflammatory bone infection

NORTHSTAR MEDICAL RADIOISOTOPES: Announces FDA Approval for Enhanced U.S. Mo-99 Radioisotope Production Capacity

NORTHSTAR MEDICAL RADIOISOTOPES: Announces FDA Approval for Enhanced U.S. Mo-99 Radioisotope Production Capacity

Concentrated molybdenum-98 (cMo-98) enables up to four-fold increase of critical medical radioisotope Mo-99 production in U.S.

King & Spalding announced that Marisa Maleck rejoins the firm as a partner in the FDA and Life Sciences team

KING & SPALDING: FDA and Life Sciences Team Adds Partner in Washington

King & Spalding announced that Marisa Maleck rejoins the firm as a partner in the FDA and Life Sciences team, which is part of the Government Matters practice.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from FDA Reporter.